HO MAYKIN 1646395 Data last updated 2024-05-11 06:58:14 -0500 US CDT
Latest Holdings
Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.
Non-derivative Transactions CSV download
Tips: type "code_s" to show transactions with code "S".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-24 | 2023-05-23 | 2023-05-23 | 4 | Ho Maykin | DIRECTOR | acq | 4190.0 | 25.18 | 0.22 | 0.0 | Direct | Common Stock | BIOMARIN PHARMACEUTICAL INC | code A | 16640.0 | 187.7 (BMRN) |
| 2023-06-09 | 2023-06-07 | 2023-06-07 | 4 | Ho Maykin | DIRECTOR | acq | 8289.0 | 20.71 | 0.85 | 0.0 | Direct | Common Stock | FIBROGEN INC | code A | 40021.0 | 97.58 (FGEN) |
| 2023-06-09 | 2023-06-07 | 2023-06-08 | 4 | Ho Maykin | DIRECTOR | dsp | 8520.0 | 21.29 | 0.87 | 17.44 | Direct | Common Stock | FIBROGEN INC | code S | 31501.0
|
97.58 (FGEN) |
| 2023-06-23 | 2023-06-21 | 2023-06-21 | 4 | Ho Maykin | DIRECTOR | acq | 4975.0 | 43.17 | 0.9 | 0.0 | Direct | Common Stock | AGIOS PHARMACEUTICALS, INC. | code M | 11524.0 | 55.58 (AGIO) |
Derivative Transactions
Tips: type "code_m" to show transactions with code "M".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-09 | 2023-06-07 | 2023-06-07 | 4 | Ho Maykin | DIRECTOR | acq | 12666.0 | 100.0 | 1.3 | 17.13 | Direct | Stock Option (Right To Buy) | FIBROGEN INC | code A | 12666.0 | 97.58 (FGEN) |
| 2023-06-15 | 2023-06-13 | 2023-06-13 | 4 | Ho Maykin | DIRECTOR | acq | 3388.0 | 100.0 | 0.61 | 0.0 | Direct | Restricted Stock Units | AGIOS PHARMACEUTICALS, INC. | code A | 3388.0 | 55.58 (AGIO) |
| 2023-06-15 | 2023-06-13 | 2023-06-13 | 4 | Ho Maykin | DIRECTOR | acq | 18958.0 | 100.0 | 3.41 | 26.56 | Direct | Stock Options (Right To Buy) | AGIOS PHARMACEUTICALS, INC. | code A | 18958.0 | 55.58 (AGIO) |
| 2023-06-23 | 2023-06-21 | 2023-06-21 | 4 | Ho Maykin | DIRECTOR | dsp | 4975.0 | 100.0 | 0.9 | 0.0 | Direct | Restricted Stock Unit | AGIOS PHARMACEUTICALS, INC. | code M | 0.0 | 55.58 (AGIO) |
| 2023-09-14 | 2023-09-14 | 3 | Ho Maykin | DIRECTOR | holding | 95586.0 | 0 | 2.52 | Direct | Stock Option (Right To Buy) | NEUMORA THERAPEUTICS, INC. | NA | 0.0 (NMRA) | |||
| 2023-09-18 | 2023-09-14 | 2023-09-14 | 4 | Ho Maykin | DIRECTOR | acq | 27802.0 | 100.0 | 17.0 | Direct | Stock Option (Right To Buy) | NEUMORA THERAPEUTICS, INC. | code A | 27802.0 | 0.0 (NMRA) |
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)